+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

North America Hydrocolloids Market Outlook, 2030

  • PDF Icon

    Report

  • 90 Pages
  • October 2025
  • Region: North America
  • Bonafide Research
  • ID: 6175131
10% Free customization
1h Free Analyst Time
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

In North America, the hydrocolloid industry has seen significant advancements in manufacturing processes, particularly in the areas of fermentation and extraction technologies. Companies are increasingly adopting biotechnological fermentation methods to produce hydrocolloids like xanthan gum, gellan gum, and gellan. These methods offer several advantages over traditional extraction from natural sources, including higher purity, consistency, and scalability. DuPont has invested in state-of-the-art fermentation facilities to enhance the production of microbial hydrocolloids, aiming to meet the growing demand in food, pharmaceutical, and cosmetic applications.

Similarly, Gelita AG announced a $50 million investment to expand its hydrocolloid production capacity in Iowa, USA, focusing on gelatin and collagen-based products. This expansion is expected to improve supply chain efficiency and support the increasing demand for functional ingredients in various industries. DSM-Firmenich launched a new gellan gum product designed to improve texture and stability in plant-based dairy alternatives, catering to the growing demand for vegan and lactose-free products. Similarly, Kerry Group introduced a clean-label carrageenan hydrocolloid for dairy applications, targeting manufacturers seeking natural stabilizers for yogurts and plant-based beverages.

These innovations reflect the industry's response to consumer preferences for clean-label and plant-based ingredients. In the pharmaceutical sector, companies are developing hydrocolloid-based wound dressings with enhanced properties, such as improved moisture management and controlled drug release. Strategic acquisitions and collaborations have played a pivotal role in driving innovation within the North American hydrocolloid market.

In 2024, Ingredion completed the acquisition of PureCircle, a leading producer of stevia-based hydrocolloids, strengthening its position in natural and plant-based ingredient solutions for global food manufacturers. This acquisition allows Ingredion to expand its portfolio and meet the growing consumer demand for clean-label and plant-based products. Ashland Inc. appointed Dr. Lisa Chen as CEO to accelerate innovation in specialty hydrocolloids for pharmaceutical and personal care applications, signaling a renewed focus on R&D and product development.

According to the research report "North America Hydrocolloids Market Overview, 2030,", the North America Hydrocolloids market is anticipated to grow at 7.49% CAGR from 2025 to 2030. Danisco announced collaboration with Unilever to co-develop innovative hydrocolloid-based emulsifiers for use in ice cream and frozen desserts, aiming to improve texture and stability in these products. These strategic moves highlight the industry's commitment to innovation and the development of advanced hydrocolloid solutions that cater to evolving consumer preferences and industry needs.

Gerresheimer, a German manufacturer of drug-delivery systems, invested approximately $180 million to expand its production capacity in Peachtree City, Georgia, USA. This expansion involves constructing and equipping two new buildings, adding 194,000 square feet to the site, to enhance the production of medical systems like inhalers and auto injectors.

The first stage of this expansion is nearing completion, with production at the first new building expected to start by the end of the year, and the second building operational by the end of 2025. In the medical sector, regulatory agencies are tightening standards for medical devices and food contact materials, necessitating rigorous testing and certification.

Compliance with international quality standards, such as ISO 10993 for biocompatibility and ISO 13485 for medical device quality management, is becoming a prerequisite for market entry. Manufacturers are investing in regulatory affairs and quality assurance to ensure their hydrocolloid-based products meet these stringent standards, thereby facilitating market growth and adoption in medical applications. North America serves as a significant innovation hub for the hydrocolloid industry, with a concentration of research and development activities in the United States and Canada.

The region's strong presence of leading food and beverage manufacturers, pharmaceutical companies, and research institutions fosters an environment conducive to innovation in hydrocolloid applications. For example, companies like DuPont and Cargill are investing in R&D to develop innovative hydrocolloid solutions, enhancing their market position and contributing to the growth of the industry.

Market Drivers

  • Rising Demand for Convenience and Processed Foods: The North American market, particularly in the U.S. and Canada, is experiencing strong demand for ready-to-eat and convenience foods, driven by fast-paced lifestyles, urbanization, and the growing number of working professionals. Hydrocolloids are essential in processed foods as they improve texture, shelf-life, stability, and mouthfeel. From frozen meals to instant soups and dairy-based snacks, hydrocolloids like carrageenan, guar gum, and xanthan gum are used to ensure product consistency and consumer appeal. This trend continues to drive strong growth for hydrocolloid suppliers in the region, as food manufacturers invest in innovation to meet evolving consumer expectations.
  • Health and Wellness Trends Fueling Demand for Natural Ingredients: Consumers across North America are increasingly health-conscious and seeking "clean label" products with fewer artificial additives. This shift is encouraging manufacturers to replace synthetic thickeners and stabilizers with naturally derived hydrocolloids, such as agar, pectin, and locust bean gum. These natural hydrocolloids are perceived as healthier and more sustainable, aligning with consumer preferences for organic, gluten-free, vegan, and non-GMO food products. As a result, the demand for natural hydrocolloids is accelerating across sectors such as plant-based dairy alternatives, functional beverages, and low-calorie formulations.

Market Challenges

  • Fluctuating Raw Material Prices and Supply Constraints: One of the significant challenges in the North American hydrocolloid market is the volatility in raw material prices due to factors like climate change, geopolitical tensions, and transportation disruptions. Many hydrocolloids such as agar or guar gum are imported from Asia and Africa, making North American manufacturers vulnerable to global supply chain risks. Droughts, seaweed harvesting restrictions, or logistical bottlenecks can all drive up costs and limit availability, affecting the stability of supply for food and pharmaceutical companies.
  • Regulatory and Labeling Compliance: the hydrocolloid market in North America is also challenged by strict food safety regulations and evolving labeling requirements. Agencies like the U.S. FDA and Health Canada closely monitor food additives, and certain hydrocolloids face regulatory scrutiny over their source or processing methods. For instance, synthetic or chemically modified variants like CMC may not align with consumer expectations for natural labels, and companies must navigate complex labeling laws to remain compliant while maintaining consumer trust. Meeting these regulatory standards can lead to increased production costs and delays in product innovation.

Market Trends

  • Growth of Plant-Based and Alternative Food Products: the plant-based food revolution in North America is creating substantial new demand for hydrocolloids. As consumers shift toward vegan, vegetarian, and flexitarian diets, there is a growing need for plant-based meat and dairy alternatives that replicate the texture and mouthfeel of animal-derived products. Hydrocolloids like carrageenan, methylcellulose, and pectin are key ingredients in these formulations, helping to improve texture, bind ingredients, and maintain moisture. This trend is expected to remain a major growth driver in the region, especially as innovation in plant-based foods accelerates.
  • Increased Use in Medical and Pharmaceutical Applications: Beyond food, the North American hydrocolloid market is seeing rising usage in pharmaceutical and medical products, especially in wound care, drug delivery, and dental applications. Hydrocolloid dressings are widely used in hospitals and clinics because they promote moist wound healing and protect against infection. Similarly, hydrocolloids are used in controlled drug release systems and as stabilizers in oral medications and syrups. With an aging population and growing healthcare expenditure in the U.S. and Canada, the demand for hydrocolloids in this sector is expected to continue expanding steadily.Gelatin holds the largest share in the North America hydrocolloid market by type due to its unparalleled multifunctionality and nutraceuticals, and its alignment with regional consumer preferences for protein-rich and clean-label products.
Gelatin dominates the North American hydrocolloid market by type primarily because of its versatility, functional performance, and broad applicability across multiple industries most notably food & beverage, pharmaceuticals, nutraceuticals, and personal care. Derived mainly from collagen found in animal connective tissues, gelatin possesses unique properties that are difficult to replicate with other hydrocolloids. It functions as a gelling agent, stabilizer, emulsifier, and texturizer, offering an unmatched ability to create smooth, elastic, and thermoreversible gels.

In the food industry, which constitutes the largest end-use segment in North America, gelatin is extensively used in gummies, marshmallows, desserts, and yogurt, confectionery, and meat products. Gelatin is the key ingredient in soft and hard capsules, which are widely used for over-the-counter supplements, vitamins, and prescription drugs. The aging population in North America, especially in the U.S., is increasingly turning to health supplements for joint care, bone health, and beauty-enhancing collagen products. Gelatin’s origin as a natural protein also aligns with consumer preferences for clean label and functional ingredients, driving its demand in collagen-based dietary supplements, protein powders, and skincare products.

Decades of use have established solid processing infrastructure, robust supply chains, and cost efficiencies that are difficult for alternative hydrocolloids to match. Many large food and pharmaceutical companies have invested in gelatin-based formulation technologies, and replacing it would require reformulating products at both technical and regulatory levels. Gelatin is classified as generally recognized as Safe by the U.S. FDA, which simplifies its inclusion in new product developments.

Gelling agents are the fastest-growing functional segment in the North America hydrocolloid market due to their critical role in the booming demand for plant-based along with their expanding use in pharmaceuticals, nutraceuticals and controlled release functionality.

The gelling agents segment is experiencing the fastest growth by function in the North America hydrocolloid market because of its central role in multiple high-demand industries, most notably food & beverage, pharmaceuticals, nutraceuticals, and personal care. Gelling agents are substances that enable the transformation of a liquid into a semi-solid or gel-like structure, offering firmness, stability, and texture modification functions that are indispensable in modern product development. One of the most significant drivers of this rapid growth is the rise of plant-based and vegan food trends, which have taken strong root in North American consumer culture.

As consumers move away from traditional animal-based products, manufacturers are increasingly using plant-derived hydrocolloid gelling agents like agar, pectin, carrageenan, and konjac to replicate the texture of gelatin or animal fats in plant-based meats, dairy alternatives, and vegan desserts. The growing popularity of functional and fortified foods such as protein bars, collagen gummies, and energy gels has amplified the need for gelling agents that can provide form stability, chewiness, and controlled nutrient release.

Gelling agents allow these products to hold their shape and consistency while delivering nutritional benefits in an appealing format. In addition, confectionery products, which are a massive segment of the North American food industry, depend heavily on precise gelation to create the right texture, bite, and visual appeal in products like gummies, jellies, and marshmallows.

Botanical-sourced hydrocolloids are the fastest-growing segment in the North America hydrocolloid market by source due to the increasing consumer demand for clean-label as well as their widespread use in vegan and allergen-free food and personal care products.

Botanical hydrocolloids are derived from plant-based sources such as guar, locust bean, tara, konjac, cassia, pectin, and agar. These natural substances are increasingly favored over animal-based or synthetic hydrocolloids because they align with several important trends in the North American market, particularly the growing demand for plant-based, vegan, and clean-label products. As more consumers adopt plant-forward or flexitarian lifestyles, there is a rising preference for ingredients perceived as sustainable, ethically sourced, and free from animal derivatives.

Botanical hydrocolloids like pectin and agar are being increasingly used in fruit spreads, dairy alternatives, desserts, bakery fillings, and beverages to provide gelling, thickening, and stabilizing functions without compromising clean-label standards. As North American consumers grow more educated about ingredient lists and nutritional labels, the presence of recognizable plant-based ingredients like citrus pectin or guar gum adds value and trust to the product. The nutraceutical and pharmaceutical industries are also contributing to the rapid growth of botanical hydrocolloids. As consumers gravitate toward more holistic wellness products, herbal and plant-derived ingredients are gaining momentum.

Botanical hydrocolloids are used in supplements for fiber enrichment, capsule formation, and texture modification, often with the added benefit of being natural and biodegradable. They also enable the formulation of gluten-free and allergen-friendly options, which are in high demand across various health-conscious consumer segments. Consumers are actively seeking out beauty and skincare products free from synthetic thickeners and emulsifiers, favoring natural botanical alternatives that are safe, effective, and eco-friendly. Regulatory bodies in North America, such as the FDA and USDA, also support this shift by recognizing many botanical hydrocolloids as GRAS, further easing their adoption in new product development.

The Food & Beverage segment is the fastest-growing application in the North America hydrocolloid market due to the rising consumer demand for clean-label and functional foods alongside the essential role hydrocolloids play in improving texture.

With consumers increasingly demanding healthier, plant-based, allergen-free, and clean-label foods, manufacturers are turning to hydrocolloids such as pectin, guar gum, xanthan gum, carrageenan, and gelatin to meet both functional and labeling requirements. These substances serve multiple roles in food systems, including thickening, gelling, stabilizing, emulsifying, and improving mouthfeel, making them indispensable in a wide variety of products ranging from dairy alternatives and beverages to baked goods and confectionery. The rapid growth of the plant-based food and beverage sector is a major catalyst for hydrocolloid demand.

Consumers are increasingly shifting toward vegan, vegetarian, and flexitarian diets and hydrocolloids are essential for mimicking the texture and structure of meat, dairy, and egg products. For example, carrageenan and locust bean gum are used to replicate the creaminess of dairy in plant-based milks and yogurts, while methylcellulose and xanthan gum help create the juiciness and chew of plant-based meats. The explosion of alternative protein products in the U.S. and Canada has significantly increased the use of hydrocolloids to achieve functional properties such as water retention, binding, and heat stability all critical for consumer acceptance of these newer products.

In the beverage segment, hydrocolloids are used to stabilize plant-based milk, fruit juices, nutritional drinks, and functional beverages that include added protein, fiber, or vitamins. The trend toward functional beverages drinks enhanced with collagen, probiotics, or adaptogens has created new opportunities for hydrocolloids to act as stabilizers and texture enhancers in a health-focused market.Canada is the fastest-growing country in the North America hydrocolloid market due to its rapidly expanding demand for plant-based, clean-label and increasing health awareness, and investments in sustainable food innovation.

As Canadian consumers increasingly shift toward healthier lifestyles and ethical consumption, hydrocolloids are becoming key ingredients in product formulations aimed at meeting these evolving preferences. The rise of veganism, flexitarian diets, and sustainable eating in Canada has created a booming market for plant-based dairy, meat alternatives, and functional health foods sectors that rely heavily on botanical and microbial hydrocolloids like pectin, xanthan gum, carrageenan, and agar for texture, stability, and shelf-life enhancement.

Canadian companies are leveraging these ingredients not only to replace traditional animal-based additives such as gelatin but also to deliver premium sensory experiences in new-age products such as plant-based yogurts, cheeses, and protein beverages. Health Canada and the Canadian Food Inspection Agency have been actively promoting clearer food labeling, allergen disclosure, and nutritional transparency, pushing manufacturers to reformulate using cleaner, recognizable ingredients. Hydrocolloids of botanical origin fit well into this framework, as they are often labeled simply and are Generally Recognized as Safe.

This has made hydrocolloids increasingly attractive for food developers trying to balance functionality with regulatory and consumer demands. The growth of functional and fortified foods in Canada especially in urban markets like Toronto, Vancouver, and Montreal has driven up the use of hydrocolloids in health-focused products such as high-fiber snacks, protein bars, meal replacements, and nutraceutical gummies. These products often require gelling agents, stabilizers, or thickeners that can enhance both nutritional value and product consistency.

***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.

Table of Contents

1. Executive Summary
2. Market Dynamics
2.1. Market Drivers & Opportunities
2.2. Market Restraints & Challenges
2.3. Market Trends
2.4. Supply chain Analysis
2.5. Policy & Regulatory Framework
2.6. Industry Experts Views
3. Research Methodology
3.1. Secondary Research
3.2. Primary Data Collection
3.3. Market Formation & Validation
3.4. Report Writing, Quality Check & Delivery
4. Market Structure
4.1. Market Considerate
4.2. Assumptions
4.3. Limitations
4.4. Abbreviations
4.5. Sources
4.6. Definitions
5. Economic /Demographic Snapshot
6. Global Hydrocolloids Market Outlook
6.1. Market Size By Value
6.2. Market Share By Region
6.3. Market Size and Forecast, By Geography
6.4. Market Size and Forecast, By Type
6.5. Market Size and Forecast, By Function
6.6. Market Size and Forecast, By Source
6.7. Market Size and Forecast, By Application
6.7.1. Market Size and Forecast, By Food & Beverage
7. North America Hydrocolloids Market Outlook
7.1. Market Size By Value
7.2. Market Share By Country
7.3. Market Size and Forecast, By Type
7.4. Market Size and Forecast, By Function
7.5. Market Size and Forecast, By Source
7.6. Market Size and Forecast, By Application
7.7. United States Hydrocolloids Market Outlook
7.7.1. Market Size by Value
7.7.2. Market Size and Forecast By Type
7.7.3. Market Size and Forecast By Source
7.7.4. Market Size and Forecast By Application
7.8. Canada Hydrocolloids Market Outlook
7.8.1. Market Size by Value
7.8.2. Market Size and Forecast By Type
7.8.3. Market Size and Forecast By Source
7.8.4. Market Size and Forecast By Application
7.9. Mexico Hydrocolloids Market Outlook
7.9.1. Market Size by Value
7.9.2. Market Size and Forecast By Type
7.9.3. Market Size and Forecast By Source
7.9.4. Market Size and Forecast By Application
8. Europe Hydrocolloids Market Outlook
8.1. Market Size By Value
8.2. Market Share By Country
8.3. Market Size and Forecast, By Type
8.4. Market Size and Forecast, By Function
8.5. Market Size and Forecast, By Source
8.6. Market Size and Forecast, By Application
8.7. Germany Hydrocolloids Market Outlook
8.7.1. Market Size by Value
8.7.2. Market Size and Forecast By Type
8.7.3. Market Size and Forecast By Source
8.7.4. Market Size and Forecast By Application
8.8. United Kingdom (UK) Hydrocolloids Market Outlook
8.8.1. Market Size by Value
8.8.2. Market Size and Forecast By Type
8.8.3. Market Size and Forecast By Source
8.8.4. Market Size and Forecast By Application
8.9. France Hydrocolloids Market Outlook
8.9.1. Market Size by Value
8.9.2. Market Size and Forecast By Type
8.9.3. Market Size and Forecast By Source
8.9.4. Market Size and Forecast By Application
8.10. Italy Hydrocolloids Market Outlook
8.10.1. Market Size by Value
8.10.2. Market Size and Forecast By Type
8.10.3. Market Size and Forecast By Source
8.10.4. Market Size and Forecast By Application
8.11. Spain Hydrocolloids Market Outlook
8.11.1. Market Size by Value
8.11.2. Market Size and Forecast By Type
8.11.3. Market Size and Forecast By Source
8.11.4. Market Size and Forecast By Application
8.12. Russia Hydrocolloids Market Outlook
8.12.1. Market Size by Value
8.12.2. Market Size and Forecast By Type
8.12.3. Market Size and Forecast By Source
8.12.4. Market Size and Forecast By Application
9. Asia-Pacific Hydrocolloids Market Outlook
9.1. Market Size By Value
9.2. Market Share By Country
9.3. Market Size and Forecast, By Type
9.4. Market Size and Forecast, By Function
9.5. Market Size and Forecast, By Source
9.6. Market Size and Forecast, By Application
9.7. China Hydrocolloids Market Outlook
9.7.1. Market Size by Value
9.7.2. Market Size and Forecast By Type
9.7.3. Market Size and Forecast By Source
9.7.4. Market Size and Forecast By Application
9.8. Japan Hydrocolloids Market Outlook
9.8.1. Market Size by Value
9.8.2. Market Size and Forecast By Type
9.8.3. Market Size and Forecast By Source
9.8.4. Market Size and Forecast By Application
9.9. India Hydrocolloids Market Outlook
9.9.1. Market Size by Value
9.9.2. Market Size and Forecast By Type
9.9.3. Market Size and Forecast By Source
9.9.4. Market Size and Forecast By Application
9.10. Australia Hydrocolloids Market Outlook
9.10.1. Market Size by Value
9.10.2. Market Size and Forecast By Type
9.10.3. Market Size and Forecast By Source
9.10.4. Market Size and Forecast By Application
9.11. South Korea Hydrocolloids Market Outlook
9.11.1. Market Size by Value
9.11.2. Market Size and Forecast By Type
9.11.3. Market Size and Forecast By Source
9.11.4. Market Size and Forecast By Application
10. South America Hydrocolloids Market Outlook
10.1. Market Size By Value
10.2. Market Share By Country
10.3. Market Size and Forecast, By Type
10.4. Market Size and Forecast, By Function
10.5. Market Size and Forecast, By Source
10.6. Market Size and Forecast, By Application
10.7. Brazil Hydrocolloids Market Outlook
10.7.1. Market Size by Value
10.7.2. Market Size and Forecast By Type
10.7.3. Market Size and Forecast By Source
10.7.4. Market Size and Forecast By Application
10.8. Argentina Hydrocolloids Market Outlook
10.8.1. Market Size by Value
10.8.2. Market Size and Forecast By Type
10.8.3. Market Size and Forecast By Source
10.8.4. Market Size and Forecast By Application
10.9. Colombia Hydrocolloids Market Outlook
10.9.1. Market Size by Value
10.9.2. Market Size and Forecast By Type
10.9.3. Market Size and Forecast By Source
10.9.4. Market Size and Forecast By Application
11. Middle East & Africa Hydrocolloids Market Outlook
11.1. Market Size By Value
11.2. Market Share By Country
11.3. Market Size and Forecast, By Type
11.4. Market Size and Forecast, By Function
11.5. Market Size and Forecast, By Source
11.6. Market Size and Forecast, By Application
11.7. United Arab Emirates (UAE) Hydrocolloids Market Outlook
11.7.1. Market Size by Value
11.7.2. Market Size and Forecast By Type
11.7.3. Market Size and Forecast By Source
11.7.4. Market Size and Forecast By Application
11.8. Saudi Arabia Hydrocolloids Market Outlook
11.8.1. Market Size by Value
11.8.2. Market Size and Forecast By Type
11.8.3. Market Size and Forecast By Source
11.8.4. Market Size and Forecast By Application
11.9. South Africa Hydrocolloids Market Outlook
11.9.1. Market Size by Value
11.9.2. Market Size and Forecast By Type
11.9.3. Market Size and Forecast By Source
11.9.4. Market Size and Forecast By Application
12. Competitive Landscape
12.1. Competitive Dashboard
12.2. Business Strategies Adopted by Key Players
12.3. Key Players Market Share Insights and Analysis, 2024
12.4. Key Players Market Positioning Matrix
12.5. Porter's Five Forces
12.6. Company Profile
12.6.1. Cargill, Incorporated
12.6.1.1. Company Snapshot
12.6.1.2. Company Overview
12.6.1.3. Financial Highlights
12.6.1.4. Geographic Insights
12.6.1.5. Business Segment & Performance
12.6.1.6. Product Portfolio
12.6.1.7. Key Executives
12.6.1.8. Strategic Moves & Developments
12.6.2. Ingredion Inc.
12.6.3. Tate & Lyle Public Limited Company
12.6.4. Glanbia Nutritionals Inc
12.6.5. DuPont de Nemours, Inc.
12.6.6. Archer-Daniels-Midland Company
12.6.7. Ashland Global Holdings, Inc.
12.6.8. DSM-Firmenich AG
12.6.9. Kerry Group plc
12.6.10. International Flavors & Fragrances Inc.
12.6.11. Gelymar S.A.
12.6.12. Jungbunzlauer Suisse AG
12.6.13. Darling Ingredients Inc.
12.6.14. Ingredients Network
12.6.15. Palsgaard A/S
12.6.16. Nexira SAS
12.6.17. W Hydrocolloids, Inc.
12.6.18. Lotus Gums & Chemicals
12.6.19. J.F. Hydrocolloids, Inc.
13. Strategic Recommendations
14. Annexure
14.1. FAQ`s
14.2. Notes
14.3. Related Reports
15. Disclaimer
List of Figures
Figure 1: Global Hydrocolloids Market Size (USD Billion) By Region, 2024 & 2030
Figure 2: Market attractiveness Index, By Region 2030
Figure 3: Market attractiveness Index, By Segment 2030
Figure 4: Global Hydrocolloids Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 5: Global Hydrocolloids Market Share By Region (2024)
Figure 6: North America Hydrocolloids Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 7: North America Hydrocolloids Market Share By Country (2024)
Figure 8: US Hydrocolloids Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 9: Canada Hydrocolloids Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 10: Mexico Hydrocolloids Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 11: Europe Hydrocolloids Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 12: Europe Hydrocolloids Market Share By Country (2024)
Figure 13: Germany Hydrocolloids Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 14: United Kingdom (UK) Hydrocolloids Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 15: France Hydrocolloids Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 16: Italy Hydrocolloids Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 17: Spain Hydrocolloids Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 18: Russia Hydrocolloids Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 19: Asia-Pacific Hydrocolloids Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 20: Asia-Pacific Hydrocolloids Market Share By Country (2024)
Figure 21: China Hydrocolloids Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 22: Japan Hydrocolloids Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 23: India Hydrocolloids Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 24: Australia Hydrocolloids Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 25: South Korea Hydrocolloids Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 26: South America Hydrocolloids Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 27: South America Hydrocolloids Market Share By Country (2024)
Figure 28: Brazil Hydrocolloids Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 29: Argentina Hydrocolloids Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 30: Colombia Hydrocolloids Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 31: Middle East & Africa Hydrocolloids Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 32: Middle East & Africa Hydrocolloids Market Share By Country (2024)
Figure 33: United Arab Emirates (UAE) Hydrocolloids Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 34: Saudi Arabia Hydrocolloids Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 35: South Africa Hydrocolloids Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 36: Porter's Five Forces of Global Hydrocolloids Market
List of Tables
Table 1: Global Hydrocolloids Market Snapshot, By Segmentation (2024 & 2030) (in USD Billion)
Table 2: Influencing Factors for Hydrocolloids Market, 2024
Table 3: Top 10 Counties Economic Snapshot 2022
Table 4: Economic Snapshot of Other Prominent Countries 2022
Table 5: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
Table 6: Global Hydrocolloids Market Size and Forecast, By Geography (2019 to 2030F) (In USD Billion)
Table 7: Global Hydrocolloids Market Size and Forecast, By Type (2019 to 2030F) (In USD Billion)
Table 8: Global Hydrocolloids Market Size and Forecast, By Function (2019 to 2030F) (In USD Billion)
Table 9: Global Hydrocolloids Market Size and Forecast, By Source (2019 to 2030F) (In USD Billion)
Table 10: Global Hydrocolloids Market Size and Forecast, By Application (2019 to 2030F) (In USD Billion)
Table 11: Global Hydrocolloids Market Size and Forecast, By Food & Beverage (2019 to 2030F) (In USD Billion)
Table 12: North America Hydrocolloids Market Size and Forecast, By Type (2019 to 2030F) (In USD Billion)
Table 13: North America Hydrocolloids Market Size and Forecast, By Function (2019 to 2030F) (In USD Billion)
Table 14: North America Hydrocolloids Market Size and Forecast, By Source (2019 to 2030F) (In USD Billion)
Table 15: North America Hydrocolloids Market Size and Forecast, By Application (2019 to 2030F) (In USD Billion)
Table 16: United States Hydrocolloids Market Size and Forecast By Type (2019 to 2030F) (In USD Billion)
Table 17: United States Hydrocolloids Market Size and Forecast By Source (2019 to 2030F) (In USD Billion)
Table 18: United States Hydrocolloids Market Size and Forecast By Application (2019 to 2030F) (In USD Billion)
Table 19: Canada Hydrocolloids Market Size and Forecast By Type (2019 to 2030F) (In USD Billion)
Table 20: Canada Hydrocolloids Market Size and Forecast By Source (2019 to 2030F) (In USD Billion)
Table 21: Canada Hydrocolloids Market Size and Forecast By Application (2019 to 2030F) (In USD Billion)
Table 22: Mexico Hydrocolloids Market Size and Forecast By Type (2019 to 2030F) (In USD Billion)
Table 23: Mexico Hydrocolloids Market Size and Forecast By Source (2019 to 2030F) (In USD Billion)
Table 24: Mexico Hydrocolloids Market Size and Forecast By Application (2019 to 2030F) (In USD Billion)
Table 25: Europe Hydrocolloids Market Size and Forecast, By Type (2019 to 2030F) (In USD Billion)
Table 26: Europe Hydrocolloids Market Size and Forecast, By Function (2019 to 2030F) (In USD Billion)
Table 27: Europe Hydrocolloids Market Size and Forecast, By Source (2019 to 2030F) (In USD Billion)
Table 28: Europe Hydrocolloids Market Size and Forecast, By Application (2019 to 2030F) (In USD Billion)
Table 29: Germany Hydrocolloids Market Size and Forecast By Type (2019 to 2030F) (In USD Billion)
Table 30: Germany Hydrocolloids Market Size and Forecast By Source (2019 to 2030F) (In USD Billion)
Table 31: Germany Hydrocolloids Market Size and Forecast By Application (2019 to 2030F) (In USD Billion)
Table 32: United Kingdom (UK) Hydrocolloids Market Size and Forecast By Type (2019 to 2030F) (In USD Billion)
Table 33: United Kingdom (UK) Hydrocolloids Market Size and Forecast By Source (2019 to 2030F) (In USD Billion)
Table 34: United Kingdom (UK) Hydrocolloids Market Size and Forecast By Application (2019 to 2030F) (In USD Billion)
Table 35: France Hydrocolloids Market Size and Forecast By Type (2019 to 2030F) (In USD Billion)
Table 36: France Hydrocolloids Market Size and Forecast By Source (2019 to 2030F) (In USD Billion)
Table 37: France Hydrocolloids Market Size and Forecast By Application (2019 to 2030F) (In USD Billion)
Table 38: Italy Hydrocolloids Market Size and Forecast By Type (2019 to 2030F) (In USD Billion)
Table 39: Italy Hydrocolloids Market Size and Forecast By Source (2019 to 2030F) (In USD Billion)
Table 40: Italy Hydrocolloids Market Size and Forecast By Application (2019 to 2030F) (In USD Billion)
Table 41: Spain Hydrocolloids Market Size and Forecast By Type (2019 to 2030F) (In USD Billion)
Table 42: Spain Hydrocolloids Market Size and Forecast By Source (2019 to 2030F) (In USD Billion)
Table 43: Spain Hydrocolloids Market Size and Forecast By Application (2019 to 2030F) (In USD Billion)
Table 44: Russia Hydrocolloids Market Size and Forecast By Type (2019 to 2030F) (In USD Billion)
Table 45: Russia Hydrocolloids Market Size and Forecast By Source (2019 to 2030F) (In USD Billion)
Table 46: Russia Hydrocolloids Market Size and Forecast By Application (2019 to 2030F) (In USD Billion)
Table 47: Asia-Pacific Hydrocolloids Market Size and Forecast, By Type (2019 to 2030F) (In USD Billion)
Table 48: Asia-Pacific Hydrocolloids Market Size and Forecast, By Function (2019 to 2030F) (In USD Billion)
Table 49: Asia-Pacific Hydrocolloids Market Size and Forecast, By Source (2019 to 2030F) (In USD Billion)
Table 50: Asia-Pacific Hydrocolloids Market Size and Forecast, By Application (2019 to 2030F) (In USD Billion)
Table 51: China Hydrocolloids Market Size and Forecast By Type (2019 to 2030F) (In USD Billion)
Table 52: China Hydrocolloids Market Size and Forecast By Source (2019 to 2030F) (In USD Billion)
Table 53: China Hydrocolloids Market Size and Forecast By Application (2019 to 2030F) (In USD Billion)
Table 54: Japan Hydrocolloids Market Size and Forecast By Type (2019 to 2030F) (In USD Billion)
Table 55: Japan Hydrocolloids Market Size and Forecast By Source (2019 to 2030F) (In USD Billion)
Table 56: Japan Hydrocolloids Market Size and Forecast By Application (2019 to 2030F) (In USD Billion)
Table 57: India Hydrocolloids Market Size and Forecast By Type (2019 to 2030F) (In USD Billion)
Table 58: India Hydrocolloids Market Size and Forecast By Source (2019 to 2030F) (In USD Billion)
Table 59: India Hydrocolloids Market Size and Forecast By Application (2019 to 2030F) (In USD Billion)
Table 60: Australia Hydrocolloids Market Size and Forecast By Type (2019 to 2030F) (In USD Billion)
Table 61: Australia Hydrocolloids Market Size and Forecast By Source (2019 to 2030F) (In USD Billion)
Table 62: Australia Hydrocolloids Market Size and Forecast By Application (2019 to 2030F) (In USD Billion)
Table 63: South Korea Hydrocolloids Market Size and Forecast By Type (2019 to 2030F) (In USD Billion)
Table 64: South Korea Hydrocolloids Market Size and Forecast By Source (2019 to 2030F) (In USD Billion)
Table 65: South Korea Hydrocolloids Market Size and Forecast By Application (2019 to 2030F) (In USD Billion)
Table 66: South America Hydrocolloids Market Size and Forecast, By Type (2019 to 2030F) (In USD Billion)
Table 67: South America Hydrocolloids Market Size and Forecast, By Function (2019 to 2030F) (In USD Billion)
Table 68: South America Hydrocolloids Market Size and Forecast, By Source (2019 to 2030F) (In USD Billion)
Table 69: South America Hydrocolloids Market Size and Forecast, By Application (2019 to 2030F) (In USD Billion)
Table 70: Brazil Hydrocolloids Market Size and Forecast By Type (2019 to 2030F) (In USD Billion)
Table 71: Brazil Hydrocolloids Market Size and Forecast By Source (2019 to 2030F) (In USD Billion)
Table 72: Brazil Hydrocolloids Market Size and Forecast By Application (2019 to 2030F) (In USD Billion)
Table 73: Argentina Hydrocolloids Market Size and Forecast By Type (2019 to 2030F) (In USD Billion)
Table 74: Argentina Hydrocolloids Market Size and Forecast By Source (2019 to 2030F) (In USD Billion)
Table 75: Argentina Hydrocolloids Market Size and Forecast By Application (2019 to 2030F) (In USD Billion)
Table 76: Colombia Hydrocolloids Market Size and Forecast By Type (2019 to 2030F) (In USD Billion)
Table 77: Colombia Hydrocolloids Market Size and Forecast By Source (2019 to 2030F) (In USD Billion)
Table 78: Colombia Hydrocolloids Market Size and Forecast By Application (2019 to 2030F) (In USD Billion)
Table 79: Middle East & Africa Hydrocolloids Market Size and Forecast, By Type (2019 to 2030F) (In USD Billion)
Table 80: Middle East & Africa Hydrocolloids Market Size and Forecast, By Function (2019 to 2030F) (In USD Billion)
Table 81: Middle East & Africa Hydrocolloids Market Size and Forecast, By Source (2019 to 2030F) (In USD Billion)
Table 82: Middle East & Africa Hydrocolloids Market Size and Forecast, By Application (2019 to 2030F) (In USD Billion)
Table 83: United Arab Emirates (UAE) Hydrocolloids Market Size and Forecast By Type (2019 to 2030F) (In USD Billion)
Table 84: United Arab Emirates (UAE) Hydrocolloids Market Size and Forecast By Source (2019 to 2030F) (In USD Billion)
Table 85: United Arab Emirates (UAE) Hydrocolloids Market Size and Forecast By Application (2019 to 2030F) (In USD Billion)
Table 86: Saudi Arabia Hydrocolloids Market Size and Forecast By Type (2019 to 2030F) (In USD Billion)
Table 87: Saudi Arabia Hydrocolloids Market Size and Forecast By Source (2019 to 2030F) (In USD Billion)
Table 88: Saudi Arabia Hydrocolloids Market Size and Forecast By Application (2019 to 2030F) (In USD Billion)
Table 89: South Africa Hydrocolloids Market Size and Forecast By Type (2019 to 2030F) (In USD Billion)
Table 90: South Africa Hydrocolloids Market Size and Forecast By Source (2019 to 2030F) (In USD Billion)
Table 91: South Africa Hydrocolloids Market Size and Forecast By Application (2019 to 2030F) (In USD Billion)
Table 92: Competitive Dashboard of top 5 players, 2024
Table 93: Key Players Market Share Insights and Anaylysis for Hydrocolloids Market 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Cargill, Incorporated
  • Ingredion Inc.
  • Tate & Lyle Public Limited Company
  • Glanbia Nutritionals Inc
  • DuPont de Nemours, Inc.
  • Archer-Daniels-Midland Company
  • Ashland Global Holdings, Inc.
  • DSM-Firmenich AG
  • Kerry Group plc
  • International Flavors & Fragrances Inc.
  • Gelymar S.A.
  • Jungbunzlauer Suisse AG
  • Darling Ingredients Inc.
  • Ingredients Network
  • Palsgaard A/S
  • Nexira SAS
  • W Hydrocolloids, Inc.
  • Lotus Gums & Chemicals
  • J.F. Hydrocolloids, Inc.